Elanco Animal Health (ELAN)
Healthcare · Drug Manufacturers - Specialty & Generic
4 members of Congress have disclosed 5 trades in Elanco Animal Health (ELAN) since 2022: 0 buys and 5 sales. The most recent was disclosed on Oct 10, 2025.
- Trades disclosed
- 5
- Members trading
- 4
- Buys / sells
- 0 / 5
- Reported value
- $5K–$75K
Keep following the company.
Subscribers get new congressional filings and notable insider purchases for companies they follow. Coverage varies by company.
What else is happening at ELAN
All research →Company filings and public records connected to this stock, ordered by when they became public or were first observed.
ELAN: third_quarter 2026 lobbying report
Issues related to USICA/COMPETES - provisions related to animal health Issues related to USICA/COMPETES - provisions related to animal health
Public: Oct 20, 2026, 12:26 PM EDTOriginal source ↗ELAN: third_quarter 2026 lobbying report
H.R.2203/S.1906 - Innovative FEED Act of 2025 Farm Bill - Various titles to support animal health-related topics. Several topics regarding tariff and non-tariff policies impacting the US animal health industry. Discussions related to international trade standards (ex. Codex Alimentarius, WOAH). Discussions related to the sanitary and phytosanitary agreement, no specific legislation. Discussions related to supply chain resilience. Issues related to emerging animal diseases and measures to prevent and control such diseases. Issues related to the regulation of animal medicines and biologics as we
Public: Oct 20, 2026, 9:20 AM EDTOriginal source ↗ELAN: second_quarter 2026 lobbying report
Issues related to USICA/COMPETES - provisions related to animal health Issues related to USICA/COMPETES - provisions related to animal health
Public: Jul 20, 2026, 1:57 PM EDTOriginal source ↗ELAN: second_quarter 2026 lobbying report
H.R.2203/S.1906 - Innovative FEED Act of 2025 Farm Bill - Various titles to support animal health-related topics. Several topics regarding tariff and non-tariff policies impacting the US animal health industry. Discussions related to international trade standards (ex. Codex Alimentarius, WOAH). Discussions related to the sanitary and phytosanitary agreement, no specific legislation. Discussions related to supply chain resilience. Issues related to emerging animal diseases and measures to prevent and control such diseases. Issues related to the regulation of animal medicines and biologics as we
Public: Jul 20, 2026, 12:38 PM EDTOriginal source ↗
Who traded ELAN
- Rep. Ro Khanna (D-CA-17)0 buys · 2 sales02Sep 12, 2025
- Rep. Val T. Hoyle (D-OR-4)0 buys · 1 sale01Oct 10, 2025
- Rep. Daniel S. Goldman (D-NY-10)0 buys · 1 sale01Apr 17, 2023
- Sen. Dan Sullivan (R-AK)0 buys · 1 sale01Dec 21, 2022
All trades
- Oct 10, 2025$1K–$15K
Rep. Val T. Hoyle (D-OR-4)
Sold Elanco Animal Health ELAN
$1K–$15K · Traded Sep 23, 2025 · disclosed Oct 10, 2025 · Spouse
- Sep 12, 2025$1K–$15K
Rep. Ro Khanna (D-CA-17)
Sold Elanco Animal Health ELAN
$1K–$15K · Traded Aug 5, 2025 · disclosed Sep 12, 2025 · Dependent
- Jul 8, 2024$1K–$15K
Rep. Ro Khanna (D-CA-17)
Sold Elanco Animal Health ELAN
$1K–$15K · Traded Jun 5, 2024 · disclosed Jul 8, 2024 · Spouse
- Apr 17, 2023$1K–$15K
Rep. Daniel S. Goldman (D-NY-10)
Sold (partial) Elanco Animal Health ELAN
$1K–$15K · Traded Mar 6, 2023 · disclosed Apr 17, 2023
- Dec 21, 2022$1K–$15K
Sen. Dan Sullivan (R-AK)
Sold (full) Elanco Animal Health ELAN
$1K–$15K · Traded Nov 30, 2022 · disclosed Dec 21, 2022 · Joint
From periodic transaction reports filed under the STOCK Act. Amounts are the ranges members report, and trades can be disclosed up to 45 days after they happen. Nothing here is investment advice.